Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Evelo Biosciences, Inc. - Common Stock (NQ: EVLO )

3.920 -0.080 (-2.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evelo Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Impinj (PI) Stock Down 25% Today?
Impinj (PI) stock is falling on Thursday after the radio-frequency chipmaker released its earnings report for the first quarter of 2023. 
Via InvestorPlace
Why Is Baudax Bio (BXRX) Stock Down 52% Today?
Baudax Bio (BXRX) stock is falling hard on Thursday after the pharmaceutical company announced a $4 million public stock offering. 
Via InvestorPlace
Why Is Atomera (ATOM) Stock Up 34% Today?
Atomera (ATOM) stock is taking off on Thursday following the release of its earnings report for the first quarter of 2023! 
Via InvestorPlace
Why Is Evelo Biosciences (EVLO) Stock Up 78% Today?
Evelo Biosciences (EVLO) stock is on the rise Thursday after the company said it's shifting focus toward EV development. 
Via InvestorPlace
Why Meta Platforms Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Earnings Preview: Evelo Biosciences
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
The biggest pre-market stock movers are ready to go as we dive into the latest news traders need to know about on Thursday! 
Via InvestorPlace
Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders. 
Via Benzinga
Evelo Biosciences' Atopic Dermatitis Study Cohort Misses Primary Goal Again, Shuts Study, Lays Off More Staff
Evelo Biosciences Inc (NASDAQ: EVLO) said its fourth cohort of the EDP1815 Phase 2 trial in atopic dermatitis, consistent with the first three cohorts, failed to meet the primary endpoint of the... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Evelo Biosciences Provides Clinical Updates
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences Reports that EDP2939, its First Oral Extracellular Vesicle Product Candidate, Commenced Dosing in a Phase 2 Psoriasis Trial
From Evelo Biosciences, Inc.
Via GlobeNewswire
Why WestRock Company Are Trading Lower By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Versus Systems Inc. (NASDAQ: VS) surged 270% to $2.26 after the company announced it will partner with Resolve to bring generative AI and gamification to customer payments and credit... 
Via Benzinga
Evelo Biosciences' Atopic Dermatitis Study Fails, Observes Unusually High Placebo Response Rates
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Evelo Biosciences Provides Clinical and Business Updates
From Evelo Biosciences, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 29 stocks made new 52-week lows. 
Via Benzinga
Why Venus Concept Shares Are Trading Higher By Over 63%? Here Are 58 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sintx Technologies, Inc. (NASDAQ: SINT) shares climbed 81.4% to $13.55 after the company was awarded Phase I contract for $150,000 from the Missile Defense Agency for electrochemical... 
Via Benzinga
Evelo Biosciences Announces $45 Million Loan Agreement with Horizon Technology Finance Corporation to Refinance Existing Debt
From Evelo Biosciences, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Upgrades 
Via Benzinga
Evelo Biosciences Announces Publication of Scientific Basis for SINTAX Medicines in Frontiers in Immunology
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences Reports Third Quarter 2022 Financial Results and Business Highlights
From Evelo Biosciences, Inc.
Via GlobeNewswire
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference
From Evelo Biosciences, Inc.
Via GlobeNewswire
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.